KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Regeneron Pharmaceuticals (REGN) Return on Capital Employed: 2010-2025

Historic Return on Capital Employed for Regeneron Pharmaceuticals (REGN) over the last 15 years, with Sep 2025 value amounting to 0.11%.

  • Regeneron Pharmaceuticals' Return on Capital Employed fell 1.00% to 0.11% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.11%, marking a year-over-year decrease of 1.00%. This contributed to the annual value of 0.13% for FY2024, which is 2.00% down from last year.
  • Regeneron Pharmaceuticals' Return on Capital Employed amounted to 0.11% in Q3 2025, which was down 5.51% from 0.11% recorded in Q2 2025.
  • In the past 5 years, Regeneron Pharmaceuticals' Return on Capital Employed registered a high of 0.43% during Q4 2021, and its lowest value of 0.11% during Q3 2025.
  • Moreover, its 3-year median value for Return on Capital Employed was 0.12% (2024), whereas its average is 0.13%.
  • As far as peak fluctuations go, Regeneron Pharmaceuticals' Return on Capital Employed rose by 18bps in 2021, and later decreased by 25bps in 2022.
  • Quarterly analysis of 5 years shows Regeneron Pharmaceuticals' Return on Capital Employed stood at 0.43% in 2021, then fell by 25bps to 0.19% in 2022, then decreased by 5bps to 0.14% in 2023, then dropped by 2bps to 0.12% in 2024, then fell by 1bps to 0.11% in 2025.
  • Its Return on Capital Employed was 0.11% in Q3 2025, compared to 0.11% in Q2 2025 and 0.11% in Q1 2025.